Evidence map›Paper›PMID 41002570›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Primary Retroperitoneal Mucinous Cystadenocarcinoma in a Male Patient: A Case Report.

Masayuki Tomioka, Keita Nakane, Koji Iinuma, Kota Kawase, Tomoki Taniguchi, Yuki Tobisawa, Aoi Muto, Tomohiro Kanayama, Tatsuhiko Miyazaki, Takuya Koie

Abstract readCase Reports
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masayuki TomiokaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Keita NakaneDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Koji IinumaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.
Kota KawaseDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0009-0009-8494-5717
Tomoki TaniguchiDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0002-2612-2191
Yuki TobisawaDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0001-8026-9541
Aoi MutoDepartment of Pathology, Gifu University Hospital, Gifu 5011194, Japan.
Tomohiro KanayamaDepartment of Pathology, Gifu University Hospital, Gifu 5011194, Japan.ORCID 0000-0001-8845-6827
Tatsuhiko MiyazakiDepartment of Pathology, Gifu University Hospital, Gifu 5011194, Japan.
Takuya KoieDepartment of Urology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan.ORCID 0000-0002-2980-127X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is an uncommon malignant neoplasm with few reported cases, particularly among male patients. Currently, only nine documented cases have been reported worldwide, including the present case. The present case report describes the incidental detection of PRMC in an 86-year-old male patient. Despite being offered surgical intervention, the patient initially opted against treatment. Consequently, follow-up imaging examinations were performed for 3 subsequent years. The tumor, initially measuring 31 × 32 × 31 mm, gradually increased to 58 × 60 × 59 mm. Subsequently, the patient underwent laparoscopic retroperitoneal tumor resection. Histopathological examination revealed adenocarcinoma characterized by intestinal differentiation. The patient has exhibited no evidence of disease for 1 year postoperatively. The present case is noteworthy, as this disease rarely occurs in men, thereby offering significant potential for educational and scientific contributions. Notably, the patient's age, longitudinal observation of tumor progression through imaging over a period of 3 years, and complete surgical excision of the tumor are salient features of this case. These findings may prove useful in the diagnosis and treatment strategy for male patients with PRMC.

Indexed as

Cystadenocarcinoma, MucinousRetroperitoneal NeoplasmsAged, 80 and overHumansMalemale patientprimary retroperitoneal mucinous cystadenocarcinomaretroperitoneal tumor

Identifiers

PMID41002570
PMCPMC12469086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.